To further investigate the implication of PD-L1 positivity in patients with breast cancer, its expression on both cancer cells and immune cells should be implemented in future studies with appropriate assumptions of their functionality based on clinical evidence (Marra et al., 2019; Matikas et al., 2019). Here, CD274 is linked to breast cancer.